Two potent pyrazolo-pyrimidine inhibitors of Src-family kinases were found
to enhance interleukin 4 (IL-4) and reduce interferon gamma (IFN-gamma) pro
duction in cultures of splenocytes from ovalbumin-specific TCR-transgenic B
ALB/c mice. The effect,vas increased by addition of a monoclonal antibody b
inding to domains 3/4 of CD4, while other antibodies binding to domain 1 ha
d the opposite effect. The inhibitors suppressed CD40 ligand (CD40L) expres
sion on activated CD4 T cells,,which may explain this Th2 differentiating e
ffect. More generally, the effect fits within the overall framework of sign
al attenuation in T cells driving this form of differentiation. The inhibit
ors did not revert previously induced Th1 differentiation in serial culture
s of the TCR-transgenic cells. Drugs,vith this activity are of obvious inte
rest as probes and potential therapeutic agents in autoimmune disease. (C)
1999 Academic Press.